Show simple item record

dc.contributor.authorChloe, TLY
dc.contributor.authorDominey, T
dc.contributor.authorPearson, E
dc.contributor.authorMurphy, F
dc.contributor.authorCarroll, C
dc.date.accessioned2019-02-07T15:55:35Z
dc.date.available2019-02-07T15:55:35Z
dc.date.issued2018-10
dc.identifier.urihttp://hdl.handle.net/10026.1/13277
dc.description.abstract

<jats:sec><jats:title>Objective</jats:title><jats:p>To inform pathway design for patients at high risk of an adverse outcome at 5 years post-Parkinson’s disease (PD) diagnosis.</jats:p></jats:sec><jats:sec><jats:title>Background</jats:title><jats:p>In our service, all newly diagnosed patients follow a 12 month new patient pathway, which includes assessment with PDQ-39, NMS Quest and MOCA. Use of a prognostic calculator<jats:sup>1</jats:sup> allows for refinement of the pathway according to patient need. Patients are classified as low (0–0.3), medium (0.31–0.79) or high (0.8–1) risk of an adverse outcome at 5 years (postural instability, dementia, death).</jats:p></jats:sec><jats:sec><jats:title>Aim</jats:title><jats:p>We aim to evaluate whether assessments in the newly diagnosed pathway identify additional care needs in higher risk patients.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>An evaluation was carried out of our new patient database. Individuals who had the prognostic indicator performed (n=52) were included in the evaluation.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Patients in the high risk groups were found to be older and more cognitively impaired than lower risk patients (p&lt;0.05). MOCA scores negatively correlated with NMS Quest (r=−0.44, p&lt;0.001) and PDQ-39 (r=−0.51, p&lt;0.001) suggesting as cognition becomes impaired, NMS burden increases, and quality of life is reduced.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Additional care needs were identified in high-risk patients. These findings highlight additional resources are required in this patient cohort to ensure needs are met.</jats:p></jats:sec><jats:sec><jats:title>Reference</jats:title><jats:list list-type="order"><jats:list-item><jats:p>. Velseboer DC, et al. Development and external validation of a prognostic model in newly diagnosed Parkinson disease.</jats:p></jats:list-item></jats:list></jats:sec>

dc.language.isoen
dc.subject32 Biomedical and Clinical Sciences
dc.subject3209 Neurosciences
dc.subject3202 Clinical Sciences
dc.subjectPrevention
dc.subjectNeurodegenerative
dc.subjectPatient Safety
dc.subjectClinical Research
dc.subjectParkinson's Disease
dc.subjectNeurosciences
dc.subjectBrain Disorders
dc.subjectAcquired Cognitive Impairment
dc.subjectAging
dc.subject7.1 Individual care needs
dc.subject7 Management of diseases and conditions
dc.subjectNeurological
dc.titleDesigning a care pathway for high risk parkinson’s patients
dc.typepresentation
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449016200054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
dc.identifier.doi10.1136/jnnp-2018-abn.53
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/FoH - Applied Parkinson's Research
plymouth.organisational-group/Plymouth/Research Groups/FoH - Community and Primary Care
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS
plymouth.organisational-group/Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR)
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeAssociation of British Neurologists 2018 Meeting
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1136/jnnp-2018-abn.53
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeOther


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV